Please login to the form below

Not currently logged in

GW Pharma's cannabis-based medicine to be tested in dementia

GW Pharma sativex nabiximols MS

Trial will be funded by Alzheimer’s Research UK

AZ says dropping MedImmune will help ‘streamline’ its R&D

Will also drop other candidates that haven’t hit the mark

Merck puts prostate cancer firmly in Keytruda’s sights

Merck and Co - US headquartersLynparza combination could open up huge new market

Biosimilar Herceptin helps Roche gain new Perjeta recommendation

Roche's Perjeta pertuzumabNICE decision puts NHS in vanguard for new use

FCB Health’s Neon attracts new managing director

Mardene Miller will lead the agency with co-managing director Kevin McHale

Lucid Group acquires digital and creative agency Bluedog

The move comes as the group celebrates its 12-year anniversary

Novartis first to benefit from NICE advice on ‘patient preference’

NICE (National for Health and Clinical Excellence)Consultancy spin-off looking to expand services

Teva will have to endure revenue 'trough' in 2019

Company looks to migrane treatment Ajovy for growth

Cancer drugs and China sustain AZ’s return to growth

Tagrisso set to become biggest seller

Q&A: Pernille Laerkegaard Hansen

Gemma Jones interviews AstraZeneca's Senior Research Director, Head of Bioscience

Featured jobs

Subscribe to our email news alerts


Add my company
Nobull Communications

Switched on Creative Communications. With an encyclopedic working knowledge of pharmaceutical industry rules and regulations, we create dynamic, intuitive and...

Latest intelligence

International Childhood Cancer Day 2019
The number of new cases per year is shocking but the journey and the outlooks have vastly improved. We've pulled together an infographic to show just what we mean with...
Immuno-oncology in 2019: the rapid evolution continues
Immunotherapy is pharma’s biggest growth driver – how will it develop in 2019?...
Mixing up Focus Groups
A nice spread of homogeneous participants in a focus groups are often a go to for reliable research outcomes but there's much to be said for mixing it up and...